![]() ADmit Therapeutics ADmit Therapeutics is a company engaged in the development of an early Alzheimer's disease diagnosis test. | ||||
Founding Date | Founding Date 1984 | Founding Date 1982 | Founding Date 2007 | Founding Date 2017 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Los Angeles, US HQ | Locations Ängelholm, SE HQ København, DK Meaux, FR Mumbai, IN New Delhi, IN Roma, IT Zoetermeer, NL see more | Locations Vancouver, CA HQ | Locations L'Hospitalet de Llobregat, ES HQ |
Employees | Employees 1701% decrease | Employees 3674% decrease | Employees 22 | Employees 13 |
Operating ⚠ | ||||
Patent Applications (US) | Patent Applications (US) 3 (Feb, 2022) | Patent Applications (US) 13 (Apr, 2022) | Patent Applications (US) N/A | Patent Applications (US) N/A |
Patents (US) | Patents (US) 6 (Feb, 2022) | Patents (US) 26 (Apr, 2022) | Patents (US) N/A | Patents (US) N/A |
Trademark Applications (US) | Trademark Applications (US) 4 (Nov, 2022) | Trademark Applications (US) 1 (Apr, 2022) | Trademark Applications (US) N/A | Trademark Applications (US) N/A |
Trademarks (US) | Trademarks (US) 6 (Nov, 2022) | Trademarks (US) 1 (Apr, 2022) | Trademarks (US) N/A | Trademarks (US) N/A |
HemoCue is a company providing medical diagnostic products for point-of-care testing.
View company
Augurex Life Sciences is a biomarker-evidence based biotechnology company.
View company
ADmit Therapeutics is a company engaged in the development of an early Alzheimer's disease diagnosis test.
View company